1. $OCR vs. $LH vs. $TMH vs. $DGX Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=OCR|LH|TMH|DGX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  2. End Of Day Scan: CCI Buy Signals $ACT $WHR $IHE $VCR $LH $TQQQ $GWPH $IYW $HYS $IWP www.dailystockplays.com

  3. @WallStJesus: UNUSUAL CALL VOL: $RENN $XL $LGF $DGX $LH $HAO $LQD $KATE

  4. UNUSUAL CALL VOL: $RENN $XL $LGF $DGX $LH $HAO $LQD $KATE

  5. $LH would it be a good fit for DGX?

  6. $LH who is the likely buyer?

  7. Laboratory Corp Of America Hldgs (LH) Marked As A Barbarian At The Gate $LH http://www.thestreet.com/story/13161503/1/laboratory-corp-of-america-hldgs-lh-marked-as-a-barbarian-at-the-gate.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  8. $LH June 125x calls also active on that $DGX move. Takeover chatter between those 2.

  9. $LH catching a rip off of $DGX. cos basically the same size. Labcorp eating Quest lunch.

  10. $CLVS strap in for another big leg up - $DGX/$LH deal chatter. Soon that will be $CLVS

  11. $LH This breakout has legs!

  12. $LH spiked higher on heavy trading volume https://newshedge.com/share/0/LKODvxHzWyhgiaPM46q6eQ

  13. Redwood Investments LLC holds an allocation of 1.4% in $LH in his US Equity Large Cap Core Investment Portfolio

  14. $LH vs. $EVHC vs. $OCR vs. $UHS Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=LH|EVHC|OCR|UHS|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  15. $LH Robert Mittelstaedt just Unloaded 1,296 shares of Laboratory Corp. of America Holdings (NYSE:LH), be careful if you are long! http://ww

  16. $OCR vs. $LH vs. $EVHC vs. $MD Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=OCR|LH|EVHC|MD|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  17. Insider Transaction: $LH Sale at $119.01 - $119.03 per share of 1296 shares by Director Mittelstaedt Robert E Jr on 2015-05-19.

  18. $LH Form 4: On May 19, 2015, Robert Mittelstaedt, Director, sold 1,296 shares at prices ranging from $119.01-119.03. Now owns 10,111 shares.

  19. $LH Form 4: On May 19, 2015, Robert Mittelstaedt, Director, exercised 1,296 NQSOs into common stock and acquired them at $59.37.

  20. Large Healthcare Equipment and Services Assets 1: $CYH 2: $THC 3: $LH Here s the Chart: http://lite.capitalmarketlabs.com/cmld3b/xy.php?sector=Healthcare+Equipment+and+Services|&x=Equal+Spaced&y=Assets+(US$+Millions)&minMarketCap=4796&maxMarketCap=12673&minRevenue=0&maxRevenue=1000000

  21. Laboratory Corporation of America Holdings director just cashed-in 1,296 options http://www.conferencecalltranscripts.org/4/summary2/?id=1717928 $LH

  22. $LH: New Insider Transaction on LH by Director MITTELSTAEDT ROBERT E JR: http://insideri.com/1200847_000112760215018039_0001127602-15-018039

  23. Wednesday’s Movers: http://www.wsnewspublishers.com/wednesdays-movers-ascena-retail-group-inc-nasdaqasna-ally-financial-inc-nyseally-walgreens-boots-alliance-inc-nasdaqwba-laboratory-corp-of-america-holdings-nyselh/158183/ $ASNA $ALLY $WBA $LH

  24. Rolling with $aks $aa $lh $aal $mu $cab $nugt $grpn waiting for direction in oil hopefully down being fundamentals are not there $dwti $uwti

  25. $LH Product Update: LabCorp announced the launch of two new Hepatitis C Virus drug resistance assays, the HCV NS5A and NS5B.